Anixa Biosciences Inc cotiza a 2.67 USD y tiene una capitalización bursátil de $93M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) t…
| Periodo | 2027-01 | 2026-09 | 2026-06 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.08 | $-0.07 | $-0.08 |
| Estimado | $-0.08 | $-0.08 | $-0.10 | $-0.09 |
| Sorpresa | — | +0.0% | +30.0% | +11.1% |
| Métrica | ANIX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -72.1% | -40.4% | -31.7% |
| ROA | -68.0% | -32.0% | -35.9% |
| Current Ratio | 8.08 | 2.84 | +5.24 |
| Debt / Equity | — | 0.28 | — |